Mechanism that prevents lethal bacteria from causing invasive disease revealed

July 7, 2014

An important development in understanding how the bacterium that causes pneumonia, meningitis and septicaemia remains harmlessly in the nose and throat has been discovered at the University of Liverpool's Institute of Infection and Global Health.

Streptococcus pneumoniae is a 'commensal', which can live harmlessly in the nasopharynx as part of the body's natural bacterial flora. However, in the very young and old it can invade the rest of the body, leading to serious diseases such as pneumonia, sepsis and meningitis, which claim up to a million lives every year worldwide.

However, the conditions that drive this bacterium from harmless commensal to major pathogen are not understood.

Scientists at the University have now uncovered the mechanisms by which this occurs and how it is regulated by the host immune system.

They found that a specialised group of white blood cells called T are activated by the pneumococcus and move to dampen down a damaging pro-inflammatory response from the host immune system.

When attack bacteria they cause inflammation and, if this inflammation is uncontrolled it can become excessive and damage host tissues, allowing the bacteria to spread into the rest of the respiratory system and other organs in the body.

The first author of the study, immunologist Dr Daniel Neill said: "These bacteria are quite happy to live in your nose and it's not in their interests to spread and kill their host. This is why they activate T regulatory cells: to keep the immune system in check and ensure their own survival.

"Our findings suggest induction of T regulatory cell responses in the upper airways reduces the risk of inflammatory damage that could lead to bacterial invasion and the development of disease.

"Understanding this process can now lead us to investigate how the bacteria go from this state to causing lethal infections."

The senior author of the study, Professor Aras Kadioglu said: "Vaccines are an essential part of our fight against this disease and have been highly successful.

"However, they do not protect us against all strains of pneumococci. Therefore, understanding the key immunological interactions with the pneumococcus, in the very first site they enter and colonise the human body is crucial to future development of better vaccines.

"In this study we have revealed how there is a delicate balance between the ability of the to colonise the host nasopharynx and the critical need of the immune system to prevent damaging inflammation in this key site.

"We hope that this will lead to developing novel therapies based on modulating the host to prevent subsequent invasive disease."

The paper 'Density and Duration of Pneumococcal Carriage Is Maintained by Transforming Growth Factor b1 and T Regulatory Cells', was published in the American Journal of Respiratory and Critical Care Medicine.

Explore further: How localized bacterial infections can turn into dangerous sepsis

Related Stories

Scientists pinpoint key ingredient in fighting pneumonia

July 19, 2012

(Medical Xpress) -- A mysterious protein produced by a wide spectrum of living things is crucial in regulating the immune response to the most common form of pneumonia, a new Yale School of Medicine study shows. The study ...

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.